TerrAscend (TSNDF) Common Equity (2020 - 2026)
TerrAscend (TSNDF) posted quarterly Common Equity of $90.9 million for Q1 2026, down 44.92% year-over-year from $165.1 million in Q1 2025, and down 8.16% quarter-over-quarter from $99.0 million in Q4 2025.
TerrAscend (TSNDF) Common Equity (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Common Equity for 7 consecutive years, with $90.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 44.92% year-over-year to $90.9 million; the TTM figure through Mar 2026 stood at $90.9 million (down 44.92% YoY), while the FY2025 annual figure was $99.0 million, down 44.0% from the prior year.
- Common Equity retreated to $90.9 million in Q1 2026 per TSNDF's latest filing, from $99.0 million in the prior quarter.
- Across five years, Common Equity topped out at $580.0 million in Q2 2022 and bottomed at $90.9 million in Q1 2026.
- Historically, Common Equity has averaged $249.1 million across 5 years, with a median of $232.1 million in 2024.
- Annual changes were most pronounced in 2022 — Common Equity jumped 186.77% — and 2025, when it sank 53.9%.
- TerrAscend's Common Equity stood at $321.2 million in 2022, then fell by 25.04% to $240.7 million in 2023, then decreased by 26.55% to $176.8 million in 2024, then slumped by 44.0% to $99.0 million in 2025, then slipped by 8.16% to $90.9 million in 2026.
- Business Quant data shows TSNDF's Common Equity at $90.9 million in Q1 2026, $99.0 million in Q4 2025, and $95.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 84.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.04 Mn |
| Mar 31, 2026 | 90.94 Mn |
| Dec 31, 2025 | 99.02 Mn |
| Sep 30, 2025 | 95.48 Mn |
| Jun 30, 2025 | 118.39 Mn |
| Mar 31, 2025 | 165.11 Mn |
| Dec 31, 2024 | 176.82 Mn |
| Sep 30, 2024 | 207.12 Mn |
| Jun 30, 2024 | 226.15 Mn |
| Mar 31, 2024 | 232.11 Mn |
| Dec 31, 2023 | 240.74 Mn |
| Sep 30, 2023 | 284.78 Mn |
| Jun 30, 2023 | 293.93 Mn |
| Mar 31, 2023 | 299.30 Mn |
| Dec 31, 2022 | 321.17 Mn |
| Sep 30, 2022 | 278.82 Mn |
| Jun 30, 2022 | 579.98 Mn |
| Mar 31, 2022 | 525.24 Mn |
| Dec 31, 2021 | 228.95 Mn |
| Sep 30, 2021 | 212.75 Mn |